RT @doctorRBC: SELECT-PsA Phase 3, Placebo, Active controlled trial of Upadacitinib in PsA 1⃣UPA 15mg or 30mg - ⬆️
Tweet Content
SELECT-PsA Phase 3, Placebo, Active controlled trial of Upadacitinib in PsA
1⃣UPA 15mg or 30mg - ⬆️PROs vs. Placebo thru 24wks
2⃣Similar improvement in UPA 15mg vs. 30mg
3⃣Both doses similar or > Adalimumab
@RheumNow #ACR20 Abs#1341 #ACRbest https://t.co/yu9IEX8tf0
Show on Archive Page
On
Display in Search Results
On